EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Analytical validation and clinical evaluation of a high-sensitivity cardiac troponin I immunoassay for use in cats

Jonathan A Lidbury, Rachel C Meyers, Ashley B Saunders, Jordan P Vitt, Sonya G Gordon, Sukjung Lim, Ryan C Fries iD, Jan S Suchodolski, Joerg M Steiner iD, Sonya Wesselowski iD

PLOS One · 08.04.2026 · 21 (4) · e0346522

DOI: 10.1371/journal.pone.0346522 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift PLOS One, online erschienen am 08.04.2026. Verfasst von Jonathan A Lidbury und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, U…. Hauptthemen laut MEDLINE: Troponin I, Cat Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac troponin I (cTnI) is a cardiac specific biomarker of myocardial damage in humans, dogs, and cats. The ADVIA Centaur XP High-Sensitivity Troponin I assay (AC-cTnI-HS) has been validated for use in humans and dogs, but not for use in cats. The study objective was to analytically validate the AC-cTnI-HS assay for use in cats and to evaluate cTnI measurements in healthy cats compared to those with cardiac disease to assess the clinical utility of this assay. Surplus serum samples from cats were used for analytical validation. Intra- and inter-assay variability, dilutional parallelism, and spiking recovery were assessed. Serum samples from 106 client-owned cats were evaluated. This group was comprised of 51 clinically healthy cats (structurally normal echocardiogram, normal systemic blood pressure, and unremarkable complete blood count and biochemistry profile), 25 cats with stage B1 hypertrophic cardiomyopathy, 7 with stage B2 hypertrophic cardiomyopathy, 7 with stage C cardiomyopathy of any type, 8 with congenital heart disease, and 8 cats with transient myocardial thickening and/or suspected to have myocarditis. Inter-assay and intra-assay coefficients of variation were between 2.7–8.3% and 1.5–4.0%, respectively. The mean ± standard deviation observed to expected ratios for dilutional parallelism and spiking recovery were 124.3 ± 42.8% and 92.9 ± 6.2%, respectively. Healthy cats had significantly lower cTnI concentrations than cats with hypertrophic cardiomyopathy stage B1 (P = 0.012), stage B2 (P = 0.004), or any cardiomyopathy ACVIM stage C (P = 0.002). The AC-cTnI-HS assay is precise, reproducible, linear, and accurate for measurement of cTnI concentrations in serum from cats. This study confirms that measurement of serum cTnI holds promise to have clinical utility as it was able to detect differences in serum cTnI concentrations between healthy cats and those with cardiac disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin ICat DiseasesAnimalsCatsImmunoassayFemaleMaleBiomarkersReproducibility of ResultsMyocardiumCardiomyopathy, HypertrophicSensitivity and Specificity

Substanzen

Troponin IBiomarkers

Autor:innen und Institutionen

  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.
  • Department of Veterinary Clinical Medicine, University of Illinois, Urbana-Champaign, Illinois, United States of America.

ORCID-Profile: Ryan C Fries, Joerg M Steiner, Sonya Wesselowski

Zitieren

APA

Lidbury, J. A., Meyers, R. C., Saunders, A. B., Vitt, J. P., Gordon, S. G., Lim, S., Fries, R. C., Suchodolski, J. S., Steiner, J. M., & Wesselowski, S. (2026). Analytical validation and clinical evaluation of a high-sensitivity cardiac troponin I immunoassay for use in cats. PLOS One, 21(4), e0346522. https://doi.org/10.1371/journal.pone.0346522

Vancouver

Lidbury JA, Meyers RC, Saunders AB, Vitt JP, Gordon SG, Lim S, et al. Analytical validation and clinical evaluation of a high-sensitivity cardiac troponin I immunoassay for use in cats. PLOS One. 2026;21(4):e0346522. doi:10.1371/journal.pone.0346522

BibTeX
@article{Lidbury2026,
  author = {Lidbury, Jonathan A and Meyers, Rachel C and Saunders, Ashley B and Vitt, Jordan P and Gordon, Sonya G and Lim, Sukjung and Fries, Ryan C and Suchodolski, Jan S and Steiner, Joerg M and Wesselowski, Sonya},
  title = {Analytical validation and clinical evaluation of a high-sensitivity cardiac troponin I immunoassay for use in cats},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0346522},
  doi = {10.1371/journal.pone.0346522}
}
Kostenlos starten →